Dual input computed tomography perfusion in evaluating the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma

Dual input computed tomography perfusion in evaluating the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma

Objective: To assess diagnostic role of multi-detector computed tomographic perfusion in evaluating the therapeutic response of trans-arterial chemo-embolization in hepatocellular carcinoma. Patients & methods: Post trans-arterial chemoembolization HCC patients underwent follow up by hepatic CT...

Full description

Bibliographic Details
Main Authors:	Logain Nabil Salem, Dina Moghazy Mohammed, Dina Hazem Ziada, M.H. Elshafey
Format:	Article
Language:	English
Published:	SpringerOpen 2018-09-01
Series:	The Egyptian Journal of Radiology and Nuclear Medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S0378603X18300391

Similar Items

Computed tomographic perfusion imaging for the prediction of response and survival to transarterial chemoembolization of hepatocellular carcinoma
by: Popovic Peter, et al.
Published: (2017-12-01)

The Use of Dual Energy Computerized Tomography to Detect Residual Viable Hepatocellular Carcinoma after Transarterial Chemoembolization
by: Pharida Pengwan, M.D., et al.
Published: (2019-05-01)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
by: Baur J, et al.
Published: (2016-06-01)

Treatment Strategy of Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Shiro Miyayama
Published: (2020-10-01)

Quantitative dual-energy CT for evaluating hepatocellular carcinoma after transarterial chemoembolization
by: Xiaofei Yue, et al.
Published: (2021-05-01)

Lipiodol retention pattern predicts transarterial chemoembolization therapeutic effect in hepatocellular carcinoma
by: Margaretha Vianny, et al.
Published: (2015-04-01)

Lipiodol retention pattern predicts transarterial chemoembolization therapeutic effect in hepatocellular carcinoma
by: Margaretha Vianny, et al.
Published: (2016-02-01)

Outcome of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
by: Hadeel A Helmi, et al.
Published: (2020-01-01)

Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma.
by: Jonggi Choi, et al.
Published: (2020-01-01)

Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient
by: Antonio Orlacchio, M.D., et al.
Published: (2020-12-01)

Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres
by: Waleed M. Hetta, et al.
Published: (2014-09-01)

Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Predictors of Survival
by: Summit Sawhney, et al.
Published: (2011-01-01)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Fateen W, et al.
Published: (2017-10-01)

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
by: Sacco R, et al.
Published: (2017-07-01)

PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
by: Sean P. Martin, et al.
Published: (2020-06-01)

Role of multislice computed tomography 3D volumetric analysis in the assessment of the therapeutic response of hepatocellular carcinoma after transarterial chemoembolization
by: Mohamed Fouad Osman, et al.
Published: (2021-07-01)

The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
by: Seong Kyun Na, et al.
Published: (2018-01-01)

A Rare Complication Following Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Wei-Chen Lin, et al.
Published: (2015-12-01)

Tumor Response Evaluation Transarterial Chemoembolization-treated Hepatocellular Carcinoma
by: Juferdy Kurniawan
Published: (2016-05-01)

Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.
by: Hao Hu, et al.
Published: (2014-01-01)

Usefulness of Cone-Beam CT-Based Liver Perfusion Mapping for Evaluating the Response of Hepatocellular Carcinoma to Conventional Transarterial Chemoembolization
by: Sun Young Choi, et al.
Published: (2021-02-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
by: Zhang W, et al.
Published: (2021-07-01)

Effectiveness of drug-eluting bead transarterial chemoembolization versus conventional transarterial chemoembolization for small hepatocellular carcinoma in Child-Pugh class A patients
by: In Joon Lee, et al.
Published: (2019-08-01)

Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma
by: Lei Chen, et al.
Published: (2020-06-01)

Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres® Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis
by: Bin Liang, et al.
Published: (2021-03-01)

Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization.
by: Youngjong Cho, et al.
Published: (2021-01-01)

Radiomics Analysis Based on Contrast-Enhanced MRI for Prediction of Therapeutic Response to Transarterial Chemoembolization in Hepatocellular Carcinoma
by: Ying Zhao, et al.
Published: (2021-03-01)

Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma
by: Qunfang Zhou, et al.
Published: (2020-11-01)

Factors Predicting Survival after Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma
by: Farina M. Hanif, et al.
Published: (2014-10-01)

Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles
by: Toshiyuki Irie, et al.
Published: (2020-01-01)

Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
by: Lv WF, et al.
Published: (2018-10-01)

Radiological response in Saudi patients undergoing transarterial chemoembolization for hepatocellular carcinoma
by: Al Fuhaid Turki, et al.
Published: (2007-01-01)

Spontaneous regression of lung metastases after transarterial chemoembolization for hepatocellular carcinoma
by: Naoko Kakuta, MD, et al.
Published: (2021-06-01)

Comparison between C-arm cone beam computed tomography and interventional angiography in transarterial chemoembolization of hepatocellular carcinoma
by: Ibraheim Ahmed Diab, et al.
Published: (2019-11-01)

Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for ≤5cm hepatocellular carcinoma: Propensity score matching analysis.
by: Baek Gyu Jun, et al.
Published: (2018-01-01)

Correction: Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization.
by: PLOS ONE Staff
Published: (2021-01-01)

Predicting Therapeutic Efficacy of Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound
by: Kazue Shiozawa, et al.
Published: (2021-02-01)

Influence of Forkhead box Q1 expression on therapeutic effect of transarterial chemoembolization after hepatocellular carcinoma surgery
by: ZHOU Yilong, et al.
Published: (2016-11-01)

Effect of acute kidney injury on the patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
by: Won Sohn, et al.
Published: (2020-01-01)

Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection.
by: Mi Young Jeon, et al.
Published: (2019-01-01)